Diabetes Treatment in UCTC
At UNIQUE CELL TREATMENT CLINIC we have achieved outstanding results treating the diabetes types I and II with fetal stem cells and we had this method approved by the Ministry of Healthcare of Ukraine recommendations in 2000. Since 1993 this diabetes treatment method developed by Professor Smikodub has been protected by numerous patents of Ukraine and many other countries. Administration of fetal stem cells results in well-marked hypoglycemic effect (decrease of level of the blood sugar), it allows reduce the exogenous insulin dose by 60–70% and helps to achieve stable and long-term remission in most cases.
Treatment Is Effective In Follwoing Cases
Effects of diabetes treatment with suspensions containing fetal stem cells
Mellitus diabetes treatment with stem-cell therapy results in significant enhancement of the patient's condition and improvement of clinical picture of the disease course. Our clinic has such experience of fetal stem cell administration at early stages of diabetes. Treatment with insulin is not required after it for a long time. After application of fetal stem cells, patients with diabetes mellitus observe normalization of hematological and immunological indices, reducing of manifestations of macro- and microangiopathy, restoration of working capacity and improvement of life quality. After our cell therapy, the progression of the disease slows down, remission periods become two or even three times longer. Fetal stem cell therapy is a great prevention of diabetes mellitus complications.
The syndrome of early posttransplantation improvements
The syndrome of early posttransplantation improvements described by Professor Smikodub includes decrease of the weakness, restoration of working capacity, sleep and appetite, improvement of complexion and skin color. This syndrome is noted in 90-95% of diabetes patients.
Enhancement of psychic and physiological condition
Such changes as burst of energy, improvement of mental capacity and thinking, disappearance of depressions and anxiety are observed in 57% of cases after cell therapy.
Glycemia decrease in patients with diabetes mellitus type I
After the diabetes treatment with suspensions containing fetal stem cells in 100% of patients the dose of administered insulin decreases. The main clinical effect develops within 2–3 months when the average initial insulin dose of 0,76 ± 0,06 units/ kg/ day decreases by 40-50%. In 85% of cases, when diabetes mellitus was treated, resulted in remission with exogenous insulin dose dropping by 35% within the first year after the therapy. Clinical remission of disease in our patients lasts on average 16 months, which significantly reduces the risk of patients' disability and improves quality and length of their life.
Immunity reconstruction after diabetes treatment
Stem cell therapy leads to reconstitution and normalization of cell and humoral immunity. Immunocorrecting effects develop in 3 months after the diabetes treatment and last for the whole period of remission.
Why Choose Us?